Search

everythinglearnresearchcommunity

for

Search:↓

Folliculitis Decalvans and Frontal Fibrosing Alopecia can coexist in people with darker skin, showing features of both conditions.

A positive anagen pull test can help detect active Lichen Planopilaris.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Macrophages are more involved in Lichen planopilaris than in Frontal fibrosing alopecia.

The study found a link between the severity of Lichen Planopilaris seen by doctors and the details seen under a microscope, and created a new way to measure this severity.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

People with lichen planopilaris often have seborrheic dermatitis, which can delay the diagnosis of lichen planopilaris.

Linear lichen planopilaris can affect the trunk, not just the face.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Hair loss from conditions like LPP and FFA can potentially be reversed with the right treatment.

AFM can help diagnose lichen planopilaris by identifying specific hair structure changes.

CCCA and lichen planopilaris have similar histological features, making them hard to distinguish.

Thalidomide significantly improved hair regrowth in a woman with lichen planopilaris.

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.

Low-dose naltrexone and platelet-rich plasma can regrow hair in lichen planopilaris.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

Up to 10% of hair loss patients might have early signs of a condition called Lichen Planopilaris.

Dermoscopy is useful for diagnosing lichen planopilaris and certain features may relate to disease duration, age, and gender.

Alopecia is not a significant predictor of thyroid disease when age and sex are considered.

LC-OCT is an effective new method for diagnosing classic lichen planopilaris.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.